The US interventional cardiology market will continue to exhibit weak growth in the next five years, but there will be pockets of healthy growth, such as in coronary thrombectomy devices. According to
IN VITRO DIAGNOSTICS Alliances Amgen Inc. Transgenomic Inc. Amgen Inc. has penned a deal with Transgenomic Inc. (diagnostics) to develop a CE-IVD test to screen metastatic colorectal cancer pa